Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2351-2355

  Miyake, Hideaki ^a   Yoshimura, Koji ^a   Hara, Isao ^a   Eto, Hiroshi ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

antisense oligonucleotides; basic fibroblast growth factor; human bladder cancer; matrix metalloproteinase; transfection

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE;

ARTICLE; BLADDER CANCER; CANCER INVASION; CELL FUNCTION; ENZYME SYNTHESIS; GENETIC TRANSFECTION; PRIORITY JOURNAL;

EID: 0030956508     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64779-7     Document Type: Article

References (32)

1. Thrasher, J. B. and Crawford, E. D.: Current management of invasive and metastatic transitional cell carcinoma of the bladder. J. Urol., 149: 957, 1993.
2. Skinner, D. G. and Lieskovsky, G.: Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J. Urol., 131: 1069, 1984.
3. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Ahmed, T., Weiselberg, L. R., Celler, N., Hollender, P. S., Herr, H. W., Sogani, P. C., Morse, M. J. and Whitmore, W. F.: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urotherium. J. Urol., 133: 403, 1985.
4. Miyake, H., Hara, I., Yoshimura, K., Eto, H., Arakawa, S., Wada, S., Chihara, K. and Kamidono, S.: Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res., 56: 2440, 1996.
5. Folkman, J. and Klagsbrun, M.: Angiogenic factors. Science, 235: 442, 1987.
6. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P. and Folkman, J.: Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 85: 241, 1993.
7. Allen, L. E. and Maher, P. A.: Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J. Cell. Physiol., 155: 368, 1993.
8. Liotta, L. A. and Stetler-Stevenson, W. G.: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51: 5054s, 1991.
9. Nakajima, M., Welch, D. R., Belloni, P. N. and Nicolson, G. L.: Degradation and basement membrane type IV collagen and lung subendotherial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47: 4869, 1987.
10. Nakajima, M., Welch, D. R., Wynn, D. M., Tsuruo, T. and Nicolson, G. L.: Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res., 53: 5802, 1993.
11. Pyke, C., Ralfkiaer, E., Tryggvason, K. and Dano, K.: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142: 359, 1993.
12. Stearns, M. E. and Wang, M.: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53: 878, 1993.
13. Davis, B., Waxman, J., Wasan, H., Abel, P., Williams, G., Krausz, T., Neal, D., Thomas, D., Hanby, A. and Balkwill, F.: Levels of matrix metalloproteinase in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53: 5365, 1993.
14. Jouanneau, J., Gavrilovic, J., Caruelle, D., Jaye, M., Moens, G., Caruelle, J. P. and Theiry, J. P.: Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. USA, 88: 2893, 1991.
15. Jouanneau, J., Moens, G., Bourgeois, Y., Poupon, M. F. and Thiery, J. P.: A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Proc. Natl. Acad. Sci. USA, 91: 286, 1994.
16. Nakajima, M. and Chop, A. M.: Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin. Cancer Biol., 2: 115, 1991.
17. Gohji, K., Nakajima, M., Fabra, A., Bucana, C. D., Eschenbach, A. C., Tsuruo, T. and Fidler, I. J.: Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn. J. Cancer Res., 85: 152, 1994.
18. Rasheed, S., Gardner, M. B., Rongey, R. W., Nelson-Rees, W. A. and Arnstein, P.: Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J. Natl. Cancer Inst., 58: 881, 1977.
19. Nishimura, R., Koizumi, T., Morisue, K., Yamanaka, N., Lalwani, R., Yoshimura, M., Nakagawa, T., Shii, K., Hasegawa, K. and Baba, S.: Expression and secretion of the β subunit of human chorionic gonadotropin by bladder carcinoma in vitro. Cancer Res., 55: 1479, 1995.
20. Yoshimura, K., Eto, H., Miyake, H., Hara, I., Arakawa, S. and Kamidono, S.: Messenger ribonucleic acids for fibroblast growth factors and their receptor in human bladder and renal cell carcinoma cell lines. Cancer Lett., 103: 91, 1996.
21. Sasada, R., Kurokawa, T., Iwane, M. and Igarashi, K.: Transformation of mouse BALA/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol. Cell. Biol., 8: 588, 1988.
22. Kurokawa, T., Sasada, R., Iwane, M. and Igarashi, K.: Cloning and expression of cDNA encoding human basic fibroblast growth factor. FEBS Lett., 213: 189, 1987.
23. Murphy, P. R., Sato, Y. and Knee, R. S.: Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibited anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol. Endo., 16: 877, 1992.
24. Watanabe, H., Hori, A., Seno, M., Kozai, M., Igarashi, K., Ichimori, Y. and Kondo, K.: A sensitive enzyme immunoassay for human basic fibroblast growth factor. Biochem. Biophys. Res. Commun., 175: 229, 1991.
25. Nakajima, M., Morikawa, K., Fabra, A., Bucana, C. D. and Fidler, I. J.: Influence of organ environment on extracellular matrix degradation activity and metastasis of human colon carcinoma cells. J. Natl. Cancer Inst., 82: 1890, 1990.
26. Albini, A., Iwamoto, Y., Kleiman, H. K., Martin, G. R., Kozlowski, J. M. and Mcewan, R. N.: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239, 1987.
27. Stetler-Stevenson, W. G.: Type IV collagenases in tumor invasion and metastasis. Cancer Metast. Rev., 9: 289, 1990.
28. Dinney, P. N., Fishbeck, R., Singn, R. K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C. D., Fidler, I. J. and Killion, J. J.: Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 154: 1532, 1995.
29. Ohtani, N., Tsukamoto, T., Masumori, N., Saiki, I., Yoneda, J. and Kumamoto, Y.: Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells. J. Urol., 151: 223, 1994.
30. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T. and Kozai, Y.: Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51: 6180, 1991.
31. Takahashi, J. A., Fukumoto, M., Kozai, Y., Ito, N., Oda, Y., Kikuchi, H. and Hatanaka, M.: Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett., 288: 65, 1991.
32. Taylor, W. R., Greenberg, A. H., Turley, E. A. and Wright, J. A.: Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF. Exp. Cell Res., 204: 295, 1993.